No more Krispy Kreme at McDonald's: Partnership ends this week
Both companies announced last week that, "after careful consideration," they have decided to stop working together.
The fast-food giant began offering three Krispy Kreme doughnut options, including Original Glazed Doughnuts, Chocolate Iced with Sprinkles Doughnuts and Chocolate Iced Kreme Filled Doughnuts, at around 2,400 McDonald's locations since March 2025.
Those offerings, however, failed to be successful and will soon be discontinued, according to the companies.
"We were excited and pleased to partner with Krispy Kreme," Alyssa Buetikofer, McDonald's USA's Chief Marketing and Customer Experience Officer said in a joint news release. "We had strong collaboration with Krispy Kreme, and they delivered a great, high-quality product for us, and while the partnership met our expectations for McDonald's and Owner/Operators, this needed to be a profitable business model for Krispy Kreme as well."
Krispy Kreme plans to prioritize expanding availability of its doughnuts while McDonald's focuses on building the success of its breakfast.
Here's what to know about the end of the Krispy Kreme and McDonald's partnership.
How to get one: Krispy Kreme celebrates Fourth of July with new collection, free doughnut
It's not immediately clear when McDonald's will officially serve its last Krispy Kreme doughnut (or if they already have), but the companies announced that their partnership officially ends on Tuesday, July 2.
Krispy Kreme did not immediately respond to USA TODAY's request for comment.
Need a break? Play the USA TODAY Daily Crossword Puzzle.
Fast food enthusiasts became aware of the companies' short-lived partnership in late 2023 with a phased test roll out of doughnuts began at 160 McDonald's restaurants in the Lexington and Louisville, Kentucky areas.
In October 2024, McDonald's restaurants in the Chicago area began selling Original Glazed and other fresh doughnuts. That same month, Krispy Kreme locations began offering customers a free doughnut if they show they show a McDonald's paper or digital receipt dated Oct. 10-14, 2024.
The two companies were initially gearing toward offering nationwide availability at participating restaurants by the end of 2026.
"Partnering with McDonald's on a national scale will provide our fans and doughnut lovers unprecedented daily access to fresh doughnuts and the joy that is Krispy Kreme," Charlesworth said in a March 2024 news release.
The test at 160 McDonald's restaurants in Lexington and Louisville was deemed "successful" as "consumer excitement and demand exceeded expectations."
Contributing: Gabe Hauari, USA TODAY
This article originally appeared on USA TODAY: Krispy Kreme, McDonalds partnership ending this week: What to know
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
17 hours ago
- Yahoo
SIGA to Host Business Update Call on August 5, 2025 Following Release of Second-Quarter 2025 Results
NEW YORK, July 29, 2025 (GLOBE NEWSWIRE) -- SIGA Technologies, Inc. (SIGA) (Nasdaq: SIGA), a commercial-stage pharmaceutical company, today announced that management will host a webcast and conference call to provide a business update at 4:30 P.M. ET on Tuesday, August 5, 2025. Participating in the call will be Diem Nguyen, Chief Executive Officer, and Daniel Luckshire, Chief Financial Officer. A live webcast of the call will also be available on the Company's website at in the Investor Relations section of the site, or by clicking here. Please log in approximately 5-10 minutes prior to the scheduled start time. Participants may access the call by dialing 1-800-717-1738 for domestic callers or 1-646-307-1865 for international callers. A replay of the call will be available for two weeks by dialing 1-844-512-2921 for domestic callers or 1-412-317-6671 for international callers and using Conference ID: 1130215. The archived webcast will be available in the Investor Relations section of the Company's website. About SIGA SIGA is a commercial-stage pharmaceutical company and leader in global health focused on the development of innovative medicines to treat and prevent infectious diseases. With a primary focus on orthopoxviruses, we are dedicated to protecting humanity against the world's most severe infectious diseases, including those that occur naturally, accidentally, or intentionally. Through partnerships with governments and public health agencies, we work to build a healthier and safer world by providing essential countermeasures against these global health threats. Our flagship product, TPOXX® (tecovirimat), is an antiviral medicine approved in the U.S. and Canada for the treatment of smallpox and authorized in Europe, the UK, and Japan for the treatment of smallpox, mpox (monkeypox), cowpox, and vaccinia complications. For more information about SIGA, visit Contacts:Suzanne Harnettsharnett@ and Investors Media Jennifer Drew-Bear, Edison GroupJdrew-bear@ Holly Stevens, CG Lifehstevens@
Yahoo
17 hours ago
- Yahoo
Boeing posts smaller loss as jet deliveries rise
(Reuters) -Boeing reported a smaller second-quarter loss on Tuesday as the U.S. planemaker ramped up jet production and deliveries, recovering from a regulatory crisis and a major strike that halted most production last year. Shares of the company rose 1.5% in premarket trading. After years of grappling with quality issues and production delays on its flagship 737 MAX, Boeing has cautiously ramped up monthly output this year. In May, the company produced 38 737s. Production has been stable since then, according to the company. "As we continue to execute our Safety & Quality Plan, there's more stability in our operations," CEO Kelly Ortberg said in a letter to Boeing employees on Tuesday. The U.S. Federal Aviation Administration had capped the production of Boeing's best selling 737 MAX jets following a mid-air panel blowout in a nearly new jet in January 2024. "We plan to seek FAA approval to increase to rate 42 when our key performance indicators (KPIs) show that we're ready," Ortberg added. It has delivered 206 737 MAX jets through the first half of the year. Wall Street closely tracks aircraft deliveries, because planemakers collect much of their payment when they hand over jets to customers. Boeing also increased 787 production at its plant in Charleston, South Carolina, from five aircraft a month to seven a month. Through the first half of the year, the planemaker has booked 668 orders, or 625 net orders after cancellations and conversions. An improvement in deliveries marks a pivotal step in Boeing's effort to rebound from years of production disruptions and crises that piled on debt, highlighting the urgency of accelerating output to restore financial stability. The planemaker posted a net loss of $612 million, or 92 cents per share, for the quarter through June, compared with $1.44 billion, or $2.33 per share, a year earlier. However, the planemaker continues to face pressure from supply chain disruptions that have delayed production and limited its ability to meet surging aerospace demand. It posted a loss of nearly $12 billion in 2024 due to challenges across its major business units including charges on its defense programs. It also remains exposed to U.S. President Donald Trump's sweeping tariffs, which could increase parts costs and further strain an already fragile supply chain. Boeing's revenue for the quarter through June rose 35% to $22.75 billion. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
17 hours ago
- Yahoo
Earnings, Trade Outlook Lift Wall Street Pre-Bell; Asia Mixed, Europe Up
Wall Street futures again pointed to fresh all-time records pre-bell Tuesday, as traders digested a Error while retrieving data Sign in to access your portfolio Error while retrieving data Error while retrieving data Error while retrieving data Error while retrieving data
